Michael Moye, President and General Manager of Idorsia US, commented: “The fact that the FDA has expedited the approval of the updated TRYVIO label to remove the REMS requirements is, I believe, a ...

November 27, 2024 Swiss pharma firm Idorsia plans debt restructuring, job cuts Idorsia plans to restructure its debt, implement cost-cutting measures and could shed up to 270 jobs in a bid to spur ...